To hear about similar clinical trials, please enter your email below
Trial Title:
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
NCT ID:
NCT05968053
Condition:
Carotid Artery Stenosis
Glioma
Intracranial Aneurysm
Intracranial Hemorrhages
Brain Tumor
Conditions: Official terms:
Brain Neoplasms
Intracranial Aneurysm
Intracranial Hemorrhages
Carotid Stenosis
Aneurysm
Hemorrhage
Conditions: Keywords:
microplastics
nanoplastics
Intracranial Aneurysm
brain tumor
Carotid Artery Stenosis
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
biological samples analysis
Description:
biological samples analysis
Summary:
Plastic particles are a ubiquitous pollutant in the living environment and food chain, so
far, plenty of studies have reported the internal exposure of microplastics and
nanoplastics in human tissues and enclosed body fluids.
Neurosurgery is the only department that can open the skull. In addition to blood and
cerebrospinal fluid, there are brain tissue and tumors in the presence of lesions.
Whether any of these microplastics and nanoplastics are present remains a mystery. This
prospective observational study will harvest biological samples of neurosurgery patients.
The objective of this research is to be able to detect microplastics and nanoplastics on
blood and operation samples of neurosurgery patients.
Criteria for eligibility:
Study pop:
Included patients age 18-80 years with any types of neurosurgery Excluded patients refuse
to participate
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Age 18-80 years
- Any type of neurosurgery
Exclusion Criteria:
·refusal of the patient to participate
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Beijing Tiantan Hospital, Capital Medical University
Address:
City:
Beijing
Zip:
100070
Country:
China
Status:
Recruiting
Contact:
Last name:
Fa Lin, MD
Phone:
13681107240
Email:
13681107240@163.com
Start date:
September 25, 2023
Completion date:
December 31, 2025
Lead sponsor:
Agency:
Beijing Tiantan Hospital
Agency class:
Other
Source:
Beijing Tiantan Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05968053
